Surgical Treatment of Various GI Tract Cancers
|
|
- Dorcas Barnett
- 8 years ago
- Views:
Transcription
1 Surgical Treatment of Various GI Tract Cancers By James Ouellette, DO, FACS, Surgical Oncology, Hepatobiliary Surgery Surgical treatment for most gastrointestinal (GI) cancers requires multidisciplinary interaction and thorough planning. This review focuses on primary tumors of the liver, bile duct and pancreas. Treatment of these tumors requires detailed investigation of the potential for surgical therapy. Timing and operative planning are significantly influenced by tumor location as well as the presence of regional or distant metastatic disease. In the case of hepatocellular carcinoma, which is most frequently associated with cirrhosis, additional considerations are required. Hepatocellular Carcinoma Hepatocellular carcinoma (HCC) is the fifth most common malignant neoplasm in men and the ninth most common in women, accounting for 500,000 to 1 million cases annually. HCC is relatively rare in the United States, with an annual incidence of fewer than 5 cases per 100,000 persons. The incidence in the U.S. is rising, however, apparently as the result of the increasing prevalence of hepatitis B and hepatitis C infection. Clinical presentation depends on the stage of disease. In the United States, where there is no systematic screening for HCC, patients usually present at a later stage. They frequently present with upper abdominal pain or discomfort, weight loss, ascites, or other sequela of portal hypertension. Jaundice is relatively uncommon but is an ominous sign if present. Tumor rupture at presentation occurs only about 5 percent of the time. Patients with known hepatitis C infection are generally screened for hepatocellular carcinoma, and typically present at earlier stages. Unfortunately, patients with hepatitis B infection, or no evidence of hepatitis, often present with larger tumors, but may in fact have fewer changes consistent with cirrhosis. Alpha-fetoprotein is a relatively reliable tumor marker for hepatocellular carcinoma, especially with levels >400ng/ml in the face of a large or rapidly growing tumor. Despite these general correlations AFP testing is not sensitive, nor specific, for HCC. In fact, a patient with a small hepatocellular carcinoma may have minimal or no elevation in AFP, while transient increases can be seen within inflammatory hepatic disease or cirrhosis. In general, an alpha-fetoprotein >200ng/ml in association with characteristic imaging findings is nearly 100 percent sensitive for HCC and therefore does not require biopsy to decide treatment. Various imaging modalities are used to diagnose HCC and typically include: CT scanning, ultrasound and MRI. Other more invasive tests can be used as well, although less often. Surgical treatment for hepatocellular carcinoma, in general, consists of surgical resection or orthotopic liver transplantation. However, most patients are not candidates for surgical resection. In fact only percent of patients will be eligible for surgery. The options for treatment may be significantly limited due to a patient s underlying cirrhosis. In the case of orthotopic liver transplantation, there are defined selection criteria which must be adhered to as well as the issue of a limitation of organs available for transplant. Once a tumor has been determined to be resectable, the decision must then be based on the extent of liver resection that can be performed. One must carefully evaluate the extent of any resection, which will depend on the size of the mass, the number of nodules, and the tumor s proximity to major vascular structures. Historic goals for surgical resection required a 1 cm margin for adequate therapy. Currently, based on comparative studies, a negative margin is the goal. In cases where the functional liver remnant is in question, portal vein embolization is a technique used to increase the functional liver remnant. This is done in Interventional Radiology with pre- and post-procedure volume analysis to assess the ability of liver regeneration and measure the anticipated remnant post-surgery. In patients who are being considered for liver transplantation, relatively rigid criteria have been set forth based on the study published by Mazzaferro, et al from Milan. These Milan criteria identify patients with cirrhosis who Oncology Services Annual Report 3
2 may be candidates for liver transplantation when hepatocellular carcinoma is present. Limitations define a patient with either a single tumor less than 5 cm or 3 tumors less than 3 cm in maximum diameter. Survival of 5 years after transplantation exceeded 60 percent with disease free survival exceeding 50 percent. These criteria have been adopted at most centers in the United States. For patients found to be unresectable, there are alternative therapies available that are used routinely. At our institution we rely on liver-directed trans-arterial chemoembolization and radioembolization. These techniques allow regional treatment within the lobar divisions of the liver in hopes of delivering therapy to the tumor involved regions. This procedure has the ability to be repeated should it be found to be effective and treatment is required again in the future. Ablative therapies are the other mechanism by which unresectable tumors can be approached. Typical treatment uses radiofrequency ablation which uses heat to destroy tumors. A high frequency-altering current is generated which induces frictional heat and eventually coagulative necrosis. Radiofrequency ablation is relatively versatile and can be used in multiple locations within the liver. It can also be used in multiple modes including percutaneously, laparoscopically and during open surgery. Though ablation is most effective in tumors less than 3 cm, it is frequently used in tumors up to 4 or 5 cm when necessary. It is not uncommon to use a combination of approaches for unresectable tumors. In our institution patients frequently get liver directed therapy and ablative techniques during their Analytic Gastrointestinal Cancer Cases* Miami Valley Hospital, Total Liver and Intrahepatic Bile Duct Pancreas Extrahepatic Bile Duct Ampulla of Vater Biliary Tract, NOS Total *Includes stage unknown Gastrointestinal Cancer Location and Stage at Diagnosis Miami Valley Hospital, AJCC Stage Subsite Total Liver Intrahepatic Bile Duct Extrahepatic Bile Duct Ampulla of Vater Biliary Tract, NOS Pancreas, head Pancreas, body Pancreas, tail Pancreas, duct Pancreas, other specified parts Pancreas, overlapping lesions Pancreas, NOS Total Miami Valley Hospital
3 course of treatment. A further description of these interventional techniques can be found in the Radiology section of this report. Other therapies that have been used include percutaneous ethanol injection, which is relatively uncommon with the widespread availability of radiofrequency or microwave ablation. Cryotherapy is no longer used as an ablation technique for the liver because of serious complications which occurred in the past. All ablative therapies carry some risk. Complications from RFA are relatively rare, and this appears to be a safe outpatient procedure whether done percutaneously or via laparoscopy. Care must be taken to avoid heated ablation close to major biliary structures to avoid injury to the biliary tree. Cancer of the Intra- and Extrahepatic Bile Duct Cholangiocarcinoma (CCA) is an extremely rare tumor comprising only 2 percent of all the cancers in the United States. It has an equal male to female ratio, and most patients are greater than 60 years of age. People of Asian descent have almost twice the incidence of other ethnicities; this is likely because of endemic chronic parasitic infestation. The etiology of the cholangiocarcinoma is not known. Increased risk for these tumors is associated with several diseases including ulcerative colitis and sclerosing cholangitis. Other factors include choledochal cysts and thorotrast exposure. There also appears to be an increased incidence in patients with parasitic infestations or hepatolithiasis. These findings indicate chronic inflammation of the bile duct likely plays a role. Adenocarcinoma is the most common histologic type of biliary cancer and cholangiocarcinoma can be divided into papillary, nodular or sclerosing types. The most common type is sclerosing, which represents 70 percent of tumors and is also more likely to be poorly differentiated with a poor prognosis. Papillary types, less than 5 percent of cases, carry the most favorable prognosis. The most common presenting findings include obstructive jaundice, which occurs in almost 90 percent of patients with extrahepatic cholangiocarcinoma. Other associated findings include weight loss, vague abdominal pain, fatigue and nausea. Elevation in liver enzymes is typically seen along with an elevated carbohydrate antigen 19-9 and carcinoembryonic antigen which can function as tumor markers for disease. Diagnostic imaging studies are typically performed to assess the location of the lesion. The location of cholangiocarcinoma dictates whether any surgical approach would be feasible. Typically, the first test performed is an ultrasound looking for ductal dilation. Further cross-sectional imaging is then necessary and includes CT scan, MRI, MRCP, and frequently ERCP which is required to attempt to perform ductal decompression. As discussed earlier, location is the most significant concern for defining the possibility of resection. Extrahepatic bile duct tumors occur near the hilum (Klatskin tumors), in mid-duct (rare), or in the distal bile duct. The definitive therapy for all extrahepatic bile duct carcinomas is complete resection. Unfortunately the overall resectability rates range anywhere from percent, depending on the location of the lesion. Hilar cholangiocarcinomas are the most technically challenging to resect, and contributing to this is the difficulty in preoperative imaging to determine the extent of disease in some cases. Hilar cholangiocarcinomas are defined according to the Bismuth-Corlette System which describes the common patterns as they occur in the biliary tree. Type 1 tumors approach the right and left bifurcation of the common hepatic duct. Type 2 tumors extend slightly to involve the proximal portion of both right and left ducts. Type 3a lesions extend into the right bile duct, whereas 3b tumors extend into the left bile duct. Lesions that extend up and into both right and left biliary trees are unresectable without liver transplantation. Vascular involvement of the hepatic artery and portal vein also need to be considered when assessing these tumors. Frequently vascular resection is required with reconstruction in order to allow margin negative resection. Because of the need for extended hepatic resections in these cases, assessment of the functional liver remnant is important. These assessments are made in similar fashion to those for hepatocellular carcinoma with similar imaging techniques. Distal cholangiocarcinomas are treated typically with surgical resection, Oncology Services Annual Report 5
4 which includes pancreatoduodenectomy for definitive therapy. This is performed similar to surgery for pancreatic adenocarcinoma. Cancer of the Pancreas Cancer of the pancreas is a rare disease with around 44,000 new patients diagnosed with this disease each year in the United States. This roughly translates to 3 percent of all new cancer diagnoses per year. Unfortunately pancreatic cancer is the fourth leading cause of cancerrelated death in the United States among both men and women. The majority of these tumors (85 percent) are adenocarcinomas arising from the ductal epithelium. The disease is rare before the age of 45, but the incidence rises sharply thereafter. There are two main types of pancreatic cancer. Most often pancreatic cancer starts in the ducts that carry pancreatic juices. This type is called exocrine pancreatic cancer. In this report, we will discuss this type of pancreatic cancer. Much less often, pancreatic cancer begins in the cells that make hormones. This type may be called endocrine pancreatic cancer or islet cell cancer. This report does not cover information regarding that kind of cancer. Pancreatic adenocarcinoma arises from cells forming ducts. Roughly 70 percent of these ductal cancers arise in the head of the pancreas. They appear as hard, irregular, gritty masses that are yellow-gray and are usually poorly demarcated. At the time of diagnosis, they are usually larger than 3 cm in diameter, and both nodal and distant metastases are also frequently present. Those originating in the body or tail of the pancreas are often larger and more likely to have spread before their presence is discovered. Pancreatic cancers are insidious tumors that can be present for long periods and grow extensively before they produce symptoms. The symptoms, once they develop, are determined by the location of the tumor in the pancreas. Those in the head of the pancreas can cause bile duct, duodenal, or pancreatic duct obstruction. Symptoms include unexplained episodes of pancreatitis, painless jaundice, nausea, vomiting, steatorrhea (fatty, floating, runny, foul-smelling stool) and unexplained weight loss. With further spread beyond the pancreas, patients may note upper abdominal or back pain when peripancreatic nerve plexuses are involved and ascites when peritoneal carcinomatosis or portal vein occlusion develops. Patients with tumors arising in the neck, body, or tail of the pancreas usually do not develop jaundice or gastric outlet obstruction. Their symptoms may be limited to unexplained weight loss and vague upper abdominal pain until the tumor has grown extensively and spread beyond the pancreas. New-onset diabetes mellitus is occasionally the first symptom of an otherwise occult pancreatic cancer. Recent studies have suggested that this form of diabetes may be mediated by a factor released from the tumor that either inhibits insulin release from islets or induces peripheral insulin resistance. The physical findings in patients with pancreatic cancer are also dependent on the location, size, and extent of the tumor. Liver nodules indicative of metastases can sometimes be felt. Metastatic subumbilical ( Sister Mary Joseph node ) and pelvic peritoneal ( Blumer s shelf ) deposits, as well as left supraclavicular lymphadenopathy ( Virchow s node ), indicate the presence of distant metastases. Malignant ascites, caused by peritoneal carcinomatosis, may also be present. With portal, splenic, or superior mesenteric vein occlusion, mesenteric venous pressures may be increased, and collateral channels, including gastroesophageal varices and caput medusae, may develop. Distal common bile duct obstruction caused by the tumor often leads to bile duct and gallbladder distention. Thus, a palpable gallbladder in a patient with painless jaundice (i.e., Courvoisier s sign) suggests the presence of a periampullary neoplasm. There are some conditions that have been shown to predispose individuals to develop pancreatic cancer. One of the most important risk factors studied is cigarette smoking. People who smoke tobacco are more likely than nonsmokers to develop the disease. Another important factor that has been studied is diabetes, but it is not completely clear whether diabetes itself is a cause of the cancer or happens in correlation because of its ubiquity in today s society. Family history of pancreatic cancer increases the risk of developing the disease especially if a first-degree relative is affected (mother, father, sister or brother). 6 Miami Valley Hospital
5 Obesity has also emerged as one of the important risk factors for the disease. Inflammation of the pancreas or pancreatitis is another risk factor. There are different types of pancreatitis based upon whether it is hereditary or not, but both conditions are known to predispose individuals to developing pancreatic cancer. Finally, there have been many studies into other genetic conditions or abnormalities ( mutations ) that are considered risk factors for this disease; these include the breast/ovarian cancer genes BRCA1 and BRCA2 as well as the Peutz-Jeghers syndrome gene STK11, P16 and many others. Ataxia- Telangictasia is also associated with increased risk of pancreatic cancer. Diagnosis of pancreatic cancer is most often a multi-dimensional endeavor, falling under blood laboratory testing, radiologic imaging, and biopsy for tissue examination under the microscope. The usual work-up includes measuring levels of liver function enzymes, biliary excretions and tumor markers named carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen (CEA). Imaging modalities usually include a highquality CT scan using a focused pancreas protocol; this provides the clinician with local extension of the tumor and provides insight into the resectability of the tumor. Magnetic resonance imaging (MRI) and positron emission tomography (PET) scans are sometimes performed as well; their usage is mostly dependent on clinical scenarios outside the scope of this report. Finally, there are real-time imaging procedures performed to obtain tissue diagnosis with cytology examination. These include CT-guided percutaneous biopsy, endoscopic ultrasound (EUS) combined with fine needle aspiration (FNA) or an endoscopic retrograde cholangiopancreatography (ERCP) with biliary brushing. Most often, however, final diagnosis occurs when tissue is removed during surgery and undergoes histologic examination by pathologists. Many surgeons believe that if a suspicious tumor is deemed resectable, negative biopsies are not sufficient to ensure a cancer does not exist. Surgical Treatment As noted earlier, tumors of the head and neck of the pancreas account for about 70 percent of pancreatic tumors. They are generally resected by a surgical procedure called pancreaticoduodenectomy (also known as the Whipple procedure). There are variations to the procedure but in essence the pancreas is resected at the neck and the surrounding structures including the duodenum, the gallbladder, and in many instances part of the stomach are resected and the small bowel is reattached to the bile duct from the liver, remaining pancreas and stomach outlet. Pancreatic body and tail tumors most often have already metastasized at time of diagnosis and extend locally to involve nodes, nerves or major vessels. Resection involves a distal pancreatectomy (removal of the end of the pancreas) either with or without splenectomy (removal of the spleen). The open end of the pancreas is then closed using different techniques. Most surgery is done with laparotomy, but advances continue to assess minimally invasive surgical approaches as they are feasible and appropriate. The technical aspects of surgery are beyond the scope of this discussion. A major part of both surgical procedures is extensive search for metastatic disease. Usually if metastatic disease is encountered in the operating room, palliative surgery could be performed to relieve the patient from obstructive or painful symptoms. In many cases a laparoscopy is done to assess this and spares patients from laparotomy if surgery is futile. Currently most patients with pancreatic adenocarcinoma are treated with chemotherapy or a combination of chemotherapy and radiation. The neoadjuvant and adjuvant approaches are discussed in the medical and radiation oncology sections. This underscores the need for a multidisciplinary evaluation of these complex cancer patients. Oncology Services Annual Report 7
Understanding. Pancreatic Cancer
Understanding Pancreatic Cancer Understanding Pancreatic Cancer The Pancreas The pancreas is an organ that is about 6 inches long. It s located deep in your belly between your stomach and backbone. Your
More informationLIVER CANCER AND TUMOURS
LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood
More informationDiagnosis and Prognosis of Pancreatic Cancer
Main Page Risk Factors Reducing Your Risk Screening Symptoms Diagnosis Treatment Overview Chemotherapy Radiation Therapy Surgical Procedures Lifestyle Changes Managing Side Effects Talking to Your Doctor
More informationTo Whipple or Not to Whipple, that is the Question: Evaluating the Resectability of Pancreatic Adenocarcinoma
August 2009 To Whipple or Not to Whipple, that is the Question: Evaluating the Resectability of Pancreatic Adenocarcinoma Christina Ramirez, Harvard Medical School Year III Gillian Lieberman, MD Agenda
More informationPancreatic Cancer. The Killer that must be discovered early. Dr Alfred Kow Wei Chieh
Pancreatic Cancer The Killer that must be discovered early 27 th June 2015 Dr Alfred Kow Wei Chieh Consultant Department of Surgery Division of HPB Surgery & Liver Transplantation & Assistant Dean (Education)
More informationTreatment of Hepatic Neoplasm
I. Policy University Health Alliance (UHA) will reimburse for treatment of hepatic neoplasm outside of systemic chemotherapy alone when determined to be medically necessary and within the medical criteria
More informationPancreatic Cancer Understanding your diagnosis
Pancreatic Cancer Understanding your diagnosis Let s Make Cancer History 1 888 939-3333 cancer.ca Pancreatic Cancer Understanding your diagnosis When you first hear that you have cancer you may feel alone
More informationA Patient s Guide to. Pancreatic Cysts. University of Michigan Comprehensive Cancer Center
A Patient s Guide to Pancreatic Cysts University of Michigan Comprehensive Cancer Center Staff of the Comprehensive Cancer Center s Multidisciplinary Pancreatic Cancer Program provided information for
More informationCANCER OF THE LIVER HEPATOCELLULAR CARCINOMA
CANCER OF THE LIVER HEPATOCELLULAR CARCINOMA WHAT IS CANCER OF THE LIVER? Hepatocellular carcinoma is the most common form and it comes from the main type of liver cell, the hepatocyte. About 3 out 4
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GASTROINTESTINAL HEPATOCELLULAR CARCINOMA GI Site Group Hepatocellular Carcinoma Authors: Dr. Jennifer Knox, Dr. Mairead McNamara 1. INTRODUCTION
More informationTreatment Guide Pancreatic Disease CHOOSING YOUR CARE
Treatment Guide Pancreatic Disease The pancreas is one of the body s great multi-taskers this dual-purpose organ is also a gland. Some people may not give much thought to the pancreas, especially those
More informationSurveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
More informationand Helicobacter pylori
Family Practice Oncology Network Upper Gastrointestinal Cancer (Suspected) Part 2 External Review Effective Date: TBD SCOPE: Part 2 of this guideline outlines recommendations for the prevention, screening,
More informationPancreatic Cancer Basics. Meghan McGurk, PA-C, MMSc Physician Assistant Department of Medical Oncology Yale Cancer Center
Pancreatic Cancer Basics Meghan McGurk, PA-C, MMSc Physician Assistant Department of Medical Oncology Yale Cancer Center Case Study Mr.T is a 36 yo male who presented in the fall of 2003, at the age of
More informationCancer of the Pancreas
Cancer of the Pancreas James H. North Jr., M.D., F.A.C.S. It is estimated that in 2007, 37,170 patients will be diagnosed with cancer of the pancreas and 33,370 patients will die of this disease. 1 The
More informationA Brief Guide to Pancreatic Cancer
A Brief Guide to Pancreatic Cancer Contributing authors; Dr. Michele Molinari MD Dr. Mark Walsh MD Dr. Ian Beauprie MD Dr. Daniel Rayson MD Elizabeth Reid P.Dt Sarah De Coutere, RN Craig s Cause Pancreatic
More informationBile Duct Diseases and Problems
Bile Duct Diseases and Problems Introduction A bile duct is a tube that carries bile between the liver and gallbladder and the intestine. Bile is a substance made by the liver that helps with digestion.
More informationCystic Neoplasms of the Pancreas: A multidisciplinary approach to the prevention and early detection of invasive pancreatic cancer.
This lecture is drawn from the continuing medical education program Finding Hope: Prevention, Early Detection and Treatment of Pancreatic Cancer, Nov, 2011. Robert P. Jury, MD Cystic Neoplasms of the Pancreas:
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: microwave_tumor_ablation 12/2011 11/2015 11/2016 11/2015 Description of Procedure or Service Microwave ablation
More informationFrequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
More informationA Patient s Guide to. Pancreatic Cancer
A Patient s Guide to Pancreatic Cancer Staff of the Comprehensive Cancer Center s Multidisciplinary Pancreatic Cancer Program provided information for this handbook GI Oncology Program, Patient Education
More informationRotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
More informationA PATIENT S GUIDE TO ABLATION THERAPY
A PATIENT S GUIDE TO ABLATION THERAPY THE DIVISION OF VASCULAR/INTERVENTIONAL RADIOLOGY THE ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL Treatment options for patients with cancer continue to expand, providing
More informationCEU Update. Pancreatic Cancer
CEU Update A semi-annual publication of the National Association for Health Professionals June 2015 Issue #0615 Pancreatic Cancer The Pancreatic Cancer Action Network, Inc. (PanCAN), established in 1999,
More informationHepatocellular Carcinoma (HCC)
Abhishek Vadalia Introduction Chemoembolization is being used with increasing frequency in the treatment of solid hepatic tumors such as Hepatocellular Carinoma (HCC) & rare Cholangiocellular Carcinoma
More informationKidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
More informationTreatment Advances for Liver Cancer
Treatment Advances for Liver Cancer Guest Expert: Wasif, MD Associate Professor of Medical Oncology Mario Strazzabosco, MD Professor of Internal Medicine, Digestive Diseases www.wnpr.org www.yalecancercenter.org
More informationThe Whipple Procedure. Sally Hodges, Ph.D.(c) Given the length and difficulty of the procedure, regardless of the diagnosis, certain
The Whipple Procedure Sally Hodges, Ph.D.(c) Preoperative procedures Given the length and difficulty of the procedure, regardless of the diagnosis, certain assurances must occur prior to offering a patient
More informationUCLA Asian Liver Program
CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,
More informationWhat you need to know. JAMES L. ABBRUZZESE, MD Chairman, Gastrointestinal Medical Oncology The University of Texas M. D. Anderson Cancer Center
Myths & Facts about pancreatic cancer What you need to know JAMES L. ABBRUZZESE, MD Chairman, Gastrointestinal Medical Oncology The University of Texas M. D. Anderson Cancer Center BEN EBRAHIMI, MD Fellow,
More informationDavid R. DeHaas, Jr. MD Sacred Heart Medical Center at RiverBend
David R. DeHaas, Jr. MD Sacred Heart Medical Center at RiverBend 1. To review the surgical history of the Whipple procedure for periampullary tumors. 2. To review the differential diagnosis for patients
More informationCarbohydrate antigen 19 9 (CA 19 9) (serum, plasma)
Carbohydrate antigen 19 9 (CA 19 9) (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Carbohydrate antigen 19 9 (CA 19 9) 1.2 Alternative names Cancer antigen 19 9, cancer antigen GI
More informationNeuroendocrine Tumors
Neuroendocrine Tumors Neuroendocrine tumors arise from cells that release a hormone in response to a signal from the nervous system. Neuro refers to the nervous system. Endocrine refers to the hormones.
More informationLIVER TUMORS PROFF. S.FLORET
LIVER TUMORS PROFF. S.FLORET NEOPLASM OF LIVER PRIMARY 1)BENIGN 2)MALIGNANT METASTATIC/SECONDARY LIVER Primary Liver Cancer the Second Killer among tumors high morbidity and mortality(20.40/100,000) etiology
More informationMetastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases.
Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Abstract This paper describes the staging, imaging, treatment, and prognosis of renal cell carcinoma. Three case studies
More informationLenox Hill Hospital Department of Surgery General Surgery Goals and Objectives
Lenox Hill Hospital Department of Surgery General Surgery Goals and Objectives Medical Knowledge and Patient Care: Residents must demonstrate knowledge and application of the pathophysiology and epidemiology
More informationClinical Practice Guidelines for Hepatocellular Carcinoma, List of Clinical Questions/Recommendations. Chapter. Grade. CQ No. 1 Interferon Therapy
Clinical Practice Guidelines for Hepatocellular Carcinoma, List of Clinical Questions/Recommendations Chapter Chapter 1 Prevention Sectio n CQ No. 1 Interferon Therapy Clinical Question 1 Does interferon
More informationIntroduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.
Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast
More informationDisease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
More informationGallbladder Cancer. What is gallbladder cancer? About the gallbladder
Gallbladder Cancer What is gallbladder cancer? Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer, and can spread to other areas of
More informationHEPATOCELLULAR CARCINOMA (HCC) RESECTION VERSUS TRANSPLANTATION. Francis Yao, M.D.
UCSF TRANSPLANT CONFERENCE - 9/28/2012 HEPATOCELLULAR CARCINOMA (HCC) RESECTION VERSUS TRANSPLANTATION Francis Yao, M.D. Professor of Clinical Medicine and Surgery Medical Director, Liver Transplantation
More informationrestricted to certain centers and certain patients, preferably in some sort of experimental trial format.
Managing Pancreatic Cancer, Part 4: Pancreatic Cancer Surgery, Complications, & the Importance of Surgical Volume Dr. Matthew Katz, Surgeon, MD Anderson Cancer Center, Houston, TX I m going to talk a little
More informationWhat will the doctor do?
Information about Pancreatic Cancer www.corecharity.org.uk What are the symptoms? What are the causes? Pancreatic Cancer explained When should I consult a doctor? What will the doctor do? How should I
More informationWHAT S WRONG WITH MY GALL BLADDER? GALL BLADDER POLYPS
WHAT S WRONG WITH MY GALL BLADDER? GALL BLADDER POLYPS This is a patient information booklet providing specific practical information about gall bladder polyps in brief. Its aim is to provide the patient
More informationA912: Kidney, Renal cell carcinoma
A912: Kidney, Renal cell carcinoma General facts of kidney cancer Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type
More informationWhat is pancreatic cancer?
Pancreatic Cancer What is pancreatic cancer? Let us explain it to you. www.anticancerfund.org www.esmo.org ESMO/ACF Patient Guide Series based on the ESMO Clinical Practice Guidelines PANCREATIC CANCER:
More information9 TUMORS OF THE PANCREAS, BILIARY TRACT, AND LIVER
9 Tumors of the Pancreas, Biliary Tract, and Liver 1 9 TUMORS OF THE PANCREAS, BILIARY TRACT, AND LIVER Steven M. Strasberg, M.D., F.A.C.S., and David C. Linehan, M.D., F.A.C.S. Numerous types of tumors
More informationHosts. New Methods for Treating Colorectal Cancer
Hosts Anees Chagpar MD Associate Professor of Surgical Oncology Francine MD Professor of Medical Oncology New Methods for Treating Colorectal Cancer Guest Expert: Scott, MD Associate Professor in the Department
More informationAcute Abdominal Pain following Bariatric Surgery. Disclosure. Objectives 8/17/2015. I have nothing to disclose
Acute Abdominal Pain following Bariatric Surgery Kathy J. Morris, DNP, APRN, FNP C, FAANP University of Nebraska Medical Center College of Nursing Disclosure I have nothing to disclose Objectives Pathophysiology
More informationHepatocellular Carcinoma Treatment Decision Tree
Treatment Decision Tree Derek DuBay, MD Assistant Professor of Surgery Liver Transplant and Hepatobiliary Surgery UAB Department of Surgery 1 UAB Liver Tumor Clinic Referrals: 205 996 5970 (phone) 205
More informationCancer of the Exocrine Pancreas, Ampulla of Vater and Distal Common Bile Duct Proforma
Cancer of the Exocrine, Ampulla of Vater and Distal Coon Bile Duct Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.03). Family name Given name(s) Sex Male Female Intersex/indeterminate
More informationVersion 1.2012. Also available at NCCN.com. Pancreatic Cancer. NCCN Guidelines for Patients. Dedicated to the memory of Randy Pausch
Pancreatic Cancer NCCN Guidelines for Patients Dedicated to the memory of Randy Pausch Also available at NCCN.com About this booklet Its purpose Learning that you have cancer can be overwhelming. The goal
More informationWhat is liver cancer?
Liver Cancer What is liver cancer? Let us explain it to you. www.anticancerfund.org www.esmo.org ESMO/ACF Patient Guide Series based on the ESMO Clinical Practice Guidelines LIVER CANCER: A GUIDE FOR PATIENTS
More informationPresumptive Cancers Due to Agent Orange Exposure & Cholangiocarcinoma (Bile Duct - Liver Fluke Cancer)
Presumptive Cancers Due to Agent Orange Exposure & Cholangiocarcinoma (Bile Duct - Liver Fluke Cancer) Presumptive Cancers Due to Agent Orange Exposure Prostate Cancer - Cancer of the prostate; one of
More informationTHYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
More informationPANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY. Dr. Shailesh V. Shrikhande
PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY Dr. Shailesh V. Shrikhande Associate Professor & Consultant Surgeon GI and HPB Surgical Oncology Tata Memorial Hospital, Mumbai INDIA HELICAL
More informationThe Whipple Operation for Pancreatic Cancer: Optimism vs. Reality. Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006
The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006 Overview Pancreatic ductal adenocarcinoma Pancreaticoduodenectomy
More informationPrimary -Benign - Malignant Secondary
TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low
More informationFacing Pancreatic Surgery? Learn about minimally invasive da Vinci Surgery
Facing Pancreatic Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Pancreatitis/Pancreatic Cancer The pancreas is an organ that produces enzymes and hormones to help your body digest
More informationPATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES.
PATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES. Radiation Oncology Sidney Kimmel Cancer Center at Johns Hopkins Last
More informationPancreatic Cancer Overview
Pancreatic Cancer Overview This overview is based on the more detailed information in our document Pancreatic Cancer. What is pancreatic cancer? To understand pancreatic cancer, it helps to know about
More informationBreast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.
Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are
More informationBreast Cancer. Presentation by Dr Mafunga
Breast Cancer Presentation by Dr Mafunga Breast cancer in the UK Breast cancer is the second most common cancer in women. Around 1 in 9 women will develop breast cancer It most commonly affects women over
More informationThe digestive system. Medicine and technology. Normal structure and function Diagnostic methods Example diseases and therapies
The digestive system Medicine and technology Normal structure and function Diagnostic methods Example diseases and therapies The digestive system An overview (1) Oesophagus Liver (hepar) Biliary system
More informationBiliary Stone Disease
Biliary Stone Disease Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm You have
More informationGuide to Understanding Breast Cancer
An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients
More informationNeoplasms of the LUNG and PLEURA
Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:
More informationOxford University Hospitals
Oxford University Hospitals NHS Trust Department of Hepatobiliary and Pancreatic Surgery About Pancreatic Surgery A guide for patients and relatives Introduction This booklet has been written to provide
More informationSmoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
More informationBREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt
Ali A. Kader, S. (2010). Breast cancer awareness for women and men. UCQ Nursing Journal of Academic Writing, Winter 2010, 70 76. BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader Two years
More informationIntroduction Pancreatic cancer is a malignant tumor within the pancreatic gland. Each year about 33,000 individuals in the United States are
1 Pancreatic cancer Introduction Pancreatic cancer is a malignant tumor within the pancreatic gland. Each year about 33,000 individuals in the United States are diagnosed with this condition, and more
More information95% of childhood kidney cancer cases are Wilms tumours. Childhood kidney cancer is extremely rare, with only 90 cases a year in
James Whale Fund for Kidney Cancer Childhood kidney cancer factsheet Kidney cancer rarely afflicts children and about 90 paediatric cases are diagnosed in the UK each year. About 75% of childhood kidney
More informationColorectal Cancer Care A Cancer Care Map for Patients
Colorectal Cancer Care A Cancer Care Map for Patients Understanding the process of care that a patient goes through in the diagnosis and treatment of colorectal cancer in BC. Colorectal Cancer Care Map
More informationOBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
More informationA Guide for Patients Living with a Biliary Metal Stent
A Guide for Patients Living with a Biliary Metal Stent What is a biliary metal stent? A biliary metal stent (also known as a bile duct stent ) is a flexible metallic tube specially designed to hold your
More informationYTTRIUM 90 MICROSPHERES THERAPY OF LIVER TUMORS
YTTRIUM 90 MICROSPHERES THERAPY OF LIVER TUMORS The information regarding placement of Yttrium 90 microsphres for the management of liver tumors on the next several pages includes questions commonly asked
More informationNon-coronary Brachytherapy
Non-coronary Brachytherapy I. Policy University Health Alliance (UHA) will reimburse for non-coronary brachytherapy when it is determined to be medically necessary and when it meets the medical criteria
More informationCancer: Pancreatic (Adult)
A02/S/b 2013/14 NHS STANDARD CONTRACT FOR CANCER: PANCREATIC (ADULT) SECTION B PART 1 - SERVICE SPECIFICATIONS Service Specification No. Service Commissioner Lead Provider Lead Period Date of Review A02/S/b
More informationLiver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco
Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common
More information190.25 - Alpha-fetoprotein
Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain
More informationHepatocellular Carcinoma: A Guide to Screening and Diagnosis
February 2012 Hepatocellular Carcinoma: A Guide to Screening and Diagnosis Reid Merryman, Harvard Medical School Year III Agenda Hepatocellular carcinoma (HCC) introduction Index patient: clinical presentation
More informationGastrointestinal Bleeding
Gastrointestinal Bleeding Introduction Gastrointestinal bleeding is a symptom of many diseases rather than a disease itself. A number of different conditions can cause gastrointestinal bleeding. Some causes
More informationThese rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.
Prostate Cancer OVERVIEW Prostate cancer is the second most common cancer diagnosed among American men, accounting for nearly 200,000 new cancer cases in the United States each year. Greater than 65% of
More informationPATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS
As a patient you must be adequately informed about your condition and the recommended surgical procedure. Please read this document carefully and ask about anything you do not understand. Please initial
More informationSeton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50
General Data Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50 The vast majority of the patients in this study were diagnosed
More informationLiver Cancer University of Michigan Comprehensive Cancer Center Multidisciplinary Liver Tumor Clinic
A Patient s Guide to Liver Cancer University of Michigan Comprehensive Cancer Center Multidisciplinary Liver Tumor Clinic Anatomy of Digestive System & Liver A Patient s Guide to Liver Cancer ii 2012 University
More informationMale. Female. Death rates from lung cancer in USA
Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita
More informationMesothelioma. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com ocft0101 Last reviewed: 03/21/2013 1
Mesothelioma Introduction Mesothelioma is a type of cancer. It starts in the tissue that lines your lungs, stomach, heart, and other organs. This tissue is called mesothelium. Most people who get this
More informationLeading the Way to Treat Liver Cancer
Leading the Way to Treat Liver Cancer Guest Expert: Sukru, MD Professor of Transplant Surgery Mario Strazzabosco, MD Professor of Internal Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale
More informationLung cancer forms in tissues of the lung, usually in the cells lining air passages.
Scan for mobile link. Lung Cancer Lung cancer usually forms in the tissue cells lining the air passages within the lungs. The two main types are small-cell lung cancer (usually found in cigarette smokers)
More informationCancer of the Pancreas
National Cancer Institute What You Need TM To Know About Cancer of the Pancreas U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Services This is only
More informationBrain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.
Brain Cancer Introduction Brain tumors are not rare. Thousands of people are diagnosed every year with tumors of the brain and the rest of the nervous system. The diagnosis and treatment of brain tumors
More informationBreast Cancer. CSC Cancer Experience Registry Member, breast cancer
ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.
More informationLung Cancer: Diagnosis, Staging and Treatment
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
More informationPancreatic Cancer Information for patients and their families
Pancreatic Cancer Information for patients and their families This handout answers common questions that are often asked by our patients and families. The information in this booklet is what we talked
More informationGallbladder - gallstones and surgery
Gallbladder - gallstones and surgery Summary Gallstones are small stones made from cholesterol, bile pigment and calcium salts, which form in a person s gall bladder. Medical treatment isn t necessary
More informationUnderstanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE
Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE Introduction This guide is designed to help you clarify and understand the decisions that need to be made about your care for the
More informationCenter for Endoscopic Research & Therapeutics
Center for Endoscopic Research & Therapeutics 5758 South Maryland Avenue (MC9028) Chicago, Illinois 60637 (773) 702-1459 www.uchospitals.edu Center for Endoscopic Research & Therapeutics To refer a patient
More informationNP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
More information